InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

REGENXBIO Inc.

RGNX Clue Score39
United States Fiscal year ends December CIK 0001590877
$8.07 -0.25% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $8.07 −75.99% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue4.6Operating income−65.3Net income−63.0EPS, diluted−2.38Fiscal year 2017Revenue10.4 +126.5%Operating income−75.9Net income−73.2EPS, diluted−2.45Fiscal year 2018Revenue218.5 +2,002.4%Operating income88.1Net income99.9EPS, diluted2.73Fiscal year 2019Revenue35.2 −83.9%Operating income−149.0Net income−94.7 −194.8%EPS, diluted−2.58 −194.5%Fiscal year 2020Revenue154.6 +338.7%Operating income−119.2Net income−111.3EPS, diluted−2.98Fiscal year 2021Revenue470.3 +204.3%Operating income160.0Net income127.8EPS, diluted2.91Fiscal year 2022Revenue112.7 −76.0%Operating income−262.9Net income−280.3 −319.3%EPS, diluted−6.50 −323.4%Fiscal year 2023Revenue90.2 −19.9%Operating income−268.1Net income−263.5EPS, diluted−6.02Fiscal year 2024Revenue83.3 −7.7%Operating income−233.3Net income−227.1EPS, diluted−4.59Fiscal year 2025Revenue170.4 +104.5%Operating income−161.2Net income−193.9EPS, diluted−3.76
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 4.6 10.4 218.5 35.2 154.6 470.3 112.7 90.2 83.3 170.4
Growth +126.5% +2,002.4% −83.9% +338.7% +204.3% −76.0% −19.9% −7.7% +104.5%
Operating income −65.3 −75.9 88.1 −149.0 −119.2 160.0 −262.9 −268.1 −233.3 −161.2
Net income −63.0 −73.2 99.9 −94.7 −111.3 127.8 −280.3 −263.5 −227.1 −193.9
Growth −194.8% −319.3%
EPS, diluted −2.38 −2.45 2.73 −2.58 −2.98 2.91 −6.50 −6.02 −4.59 −3.76
Growth −194.5% −323.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−1,423.8%Net margin−1,372.1%Free cash flow margin−1,235.7%Fiscal year 2017Operating margin−730.2%Net margin−704.0%Free cash flow margin−626.9%Fiscal year 2018Operating margin40.3%Net margin45.7%Free cash flow margin41.8%Fiscal year 2019Operating margin−422.9%Net margin−268.9%Free cash flow margin−339.0%Fiscal year 2020Operating margin−77.1%Net margin−72.0%Free cash flow margin−52.4%Fiscal year 2021Operating margin34.0%Net margin27.2%Free cash flow margin28.6%Fiscal year 2022Operating margin−233.2%Net margin−248.7%Free cash flow margin−211.3%Fiscal year 2023Operating margin−297.1%Net margin−292.0%Free cash flow margin−253.1%Fiscal year 2024Operating margin−280.0%Net margin−272.5%Free cash flow margin−210.7%Fiscal year 2025Operating margin−94.6%Net margin−113.8%Free cash flow margin−74.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −1,423.8% −730.2% 40.3% −422.9% −77.1% 34.0% −233.2% −297.1% −280.0% −94.6%
Net margin −1,372.1% −704.0% 45.7% −268.9% −72.0% 27.2% −248.7% −292.0% −272.5% −113.8%
Free cash flow margin −1,235.7% −626.9% 41.8% −339.0% −52.4% 28.6% −211.3% −253.1% −210.7% −74.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−48.6Capital expenditure−8.1Free cash flow−56.7Fiscal year 2017Operating cash flow−58.0Capital expenditure−7.2Free cash flow−65.2Fiscal year 2018Operating cash flow104.6Capital expenditure−13.3Free cash flow91.4Fiscal year 2019Operating cash flow−107.7Capital expenditure−11.7Free cash flow−119.4 −230.7%Fiscal year 2020Operating cash flow−54.1Capital expenditure−26.9Free cash flow−80.9Fiscal year 2021Operating cash flow218.9Capital expenditure−84.2Free cash flow134.7Fiscal year 2022Operating cash flow−207.5Capital expenditure−30.7Free cash flow−238.2 −276.8%Fiscal year 2023Operating cash flow−218.4Capital expenditure−10.0Free cash flow−228.4Fiscal year 2024Operating cash flow−173.1Capital expenditure−2.4Free cash flow−175.6Fiscal year 2025Operating cash flow−124.0Capital expenditure−2.4Free cash flow−126.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −48.6 −58.0 104.6 −107.7 −54.1 218.9 −207.5 −218.4 −173.1 −124.0
Capital expenditure −8.1 −7.2 −13.3 −11.7 −26.9 −84.2 −30.7 −10.0 −2.4 −2.4
Free cash flow −56.7 −65.2 91.4 −119.4 −80.9 134.7 −238.2 −228.4 −175.6 −126.4
Growth −230.7% −276.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash24.8Shareholders’ equity161.7Fiscal year 2017Cash46.7Shareholders’ equity183.0Fiscal year 2018Cash75.6Shareholders’ equity508.8Fiscal year 2019Cash69.5Shareholders’ equity450.2Fiscal year 2020Cash338.4Shareholders’ equity377.8Fiscal year 2021Cash345.2Shareholders’ equity764.3Fiscal year 2022Cash97.0Shareholders’ equity516.2Fiscal year 2023Cash34.5Shareholders’ equity311.7Fiscal year 2024Cash57.5Shareholders’ equity259.7Fiscal year 2025Cash34.5Shareholders’ equity102.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 24.8 46.7 75.6 69.5 338.4 345.2 97.0 34.5 57.5 34.5
Shareholders’ equity 161.7 183.0 508.8 450.2 377.8 764.3 516.2 311.7 259.7 102.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
4.6 10.4 218.5 35.2 154.6 470.3 112.7 90.2 83.3 170.4
Growth +126.5% +2,002.4% −83.9% +338.7% +204.3% −76.0% −19.9% −7.7% +104.5%
n/a 1.7 9.6 8.2 35.7 51.8 54.5 37.2 33.6 n/a
45.5 57.2 83.9 124.2 166.3 181.4 242.5 232.3 208.5 228.3
23.6 27.2 36.9 51.8 63.8 79.3 85.3 88.5 76.6 82.9
−65.3 −75.9 88.1 −149.0 −119.2 160.0 −262.9 −268.1 −233.3 −161.2
Growth −269.1% −264.3%
−63.4 −73.2 104.1 −97.5 −106.0 141.2 −280.4 −263.6 −227.1 −193.9
−0.4 0.0 4.2 −2.8 5.2 13.4 −0.1 −0.2 0.0 0.0
−63.0 −73.2 99.9 −94.7 −111.3 127.8 −280.3 −263.5 −227.1 −193.9
Growth −194.8% −319.3%
Per share
−2.38 −2.45 2.99 −2.58 −2.98 3.01 −6.50 −6.02 −4.59 −3.76
−2.38 −2.45 2.73 −2.58 −2.98 2.91 −6.50 −6.02 −4.59 −3.76
Growth −194.5% −323.4%
26.4 29.9 33.4 36.7 37.3 42.4 43.2 43.7 49.5 51.6
26.4 29.9 36.6 36.7 37.3 43.9 43.2 43.7 49.5 51.6
Growth +13.1% +22.7% +0.1% +1.6% +17.8% −1.7% +1.3% +13.2% +4.2%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 2.0% a year over five years.
  • The diluted share count rose 38.3% in five years, which is dilution.
  • Operating margin is down 17.4 points on five years ago, at -94.6%.
  • A net loss in 8 of 10 years on file.